Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer

• Published in: Japanese journal of radiology Vol. 42; no. 11; pp. 1322 - 1329
• Main Authors: Kamitani, Nobuhiko, Watanabe, Kenta, Ikeda, Naoki, Kawata, Yujiro, Tokiya, Ryoji, Hayashi, Takafumi, Miyaji, Yoshiyuki, Tamada, Tsutomu, Katsui, Kuniaki
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.11.2024; Springer Nature B.V
• Subjects: Biological effects; Brachytherapy; Effectiveness; Endocrine therapy; Imaging; Medicine; Medicine & Public Health; Nuclear Medicine; Original; Original Article; Prostate cancer; Prostate-specific antigen; Radiation dosage; Radiation therapy; Radiology; Radiotherapy; Risk; Risk groups; Survival; High-dose-rate brachytherapy; Radiotherapy; Prostate cancer; High-risk; Localized; Without hormone therapy

Purpose Until March 2018, patients with high-risk localized prostate cancer had been administered high-dose-rate brachytherapy (HDR-BT) combined with external beam radiotherapy (EBRT) without additional hormone therapy (HT) at our institution. In this study, we aimed to evaluate long-term outcomes o...